Skip to main content
OSCR
NYSE Finance

Oscar Health Lifts FY26 Operating Income Guidance by $100M and Tightens MLR Outlook

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Financial
Sentiment info
Positive
Importance info
7
Price
$32.34
Mkt Cap
$8.871B
52W Low
$10.69
52W High
$34.48
52W Position info
203% above low
Off High info
6.2% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

OSCR has more than doubled off its 52-week low of $10.69.

Summary

Oscar Health raised FY2026 operating income guidance by $100M and improved its MLR outlook by 50 bps, while reaffirming revenue and SG&A targets.


Key Events · Earnings and Guidance · OSCR

  • Operating Income Guidance Raised by $100M

    Full-year 2026 Earnings from Operations guidance increased to $600M-$800M, up from the prior $500M-$700M range.

  • Medical Loss Ratio Outlook Improved

    FY2026 MLR guidance improved 50 bps to 81.0%-82.0%, from the prior 81.5%-82.5% range.

  • Revenue and SG&A Targets Reaffirmed

    Total Revenue guidance of $18.7B-$19.0B and SG&A Expense Ratio of 15.6%-16.1% were reaffirmed.

  • Investor Day Presentation

    Guidance update disclosed at the company's 2026 Investor Day on September 16, 2026, with webcast archived for 90 days.


Analysis · OSCR · Finance

A meaningful upward revision to profitability expectations came as Oscar Health raised its full-year 2026 Earnings from Operations guidance by $100 million to a range of $600 million to $800 million, while also improving its Medical Loss Ratio outlook by 50 basis points to 81.0%-82.0%. The company reaffirmed revenue guidance of $18.7 billion to $19.0 billion. This update follows record first-half results reported in August and signals management's confidence in continued operating leverage and disciplined medical cost management through year-end.

How filings like this one have moved

In the 30 days to Oct 19, 2026, 29.4% of the 1386 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, OSCR was trading at $32.34 on NYSE in the Finance sector, with a market capitalization of approximately $8.9B. The 52-week trading range was $10.69 to $34.48. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OSCR - Latest Insights

OSCR
Sep 16, 2026, 6:20 AM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $32.50
Real-time Price: $32.44 info
Change: -$0.060 (-0.18%) info
Market Cap: $8.899B info
OSCR
Aug 31, 2026, 4:16 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $30.17
Real-time Price: $32.44 info
Change: +$2.27 (+8%) info
Market Cap: $8.899B info
OSCR
Aug 06, 2026, 12:31 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $26.76
Real-time Price: $32.44 info
Change: +$5.68 (+21%) info
Market Cap: $8.899B info
OSCR
Aug 06, 2026, 6:08 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $34.47
Real-time Price: $32.44 info
Change: -$2.03 (-6%) info
Market Cap: $8.899B info
OSCR
Aug 06, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $30.85
Real-time Price: $32.44 info
Change: +$1.59 (+5%) info
Market Cap: $8.899B info